Clinical Trials
10 trialsNCT05307328 2025-10-08
RESCUE
Sparrow Pharmaceuticals
Phase 2 Completed
NCT03697109 2025-07-16
GRACE
Corcept Therapeutics
Phase 3 Completed
NCT06576336 2024-08-28
3DAdrenal
University of Palermo
Phase 4 Completed
NCT04373265 2024-02-23
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Corcept Therapeutics
Phase 1 Completed
NCT05361083 2022-05-04
First-in-human Evaluation of [18F]CETO
Uppsala University
Phase EARLY_PHASE1 Completed
NCT02804750 2019-10-15
Study to Evaluate CORT125134 in Participants With Cushing's Syndrome
Corcept Therapeutics
Phase 2 Completed
NCT03830593 2019-10-10
Laparoscopic Adrenalectomy for Large Adrenal Tumors.
Samsun Liv Hospital
Completed
NCT00936741 2014-04-02
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Corcept Therapeutics
Phase 3 Completed
NCT01371565 2014-03-18
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
Corcept Therapeutics
Phase 3 Completed
NCT00569582 2013-08-22
SEISMIC
Corcept Therapeutics
Phase 3 Completed